Qiagen N.V.
QIAGEN N.V.: Release of a capital market information
QIAGEN N.V. / Share Buyback 16.10.2018 / 10:41 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase - Interim Reporting With disclosure dated September 05, 2018, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate beginning of a second tranche of up to USD 50 million under the share repurchase program originally announced on January 31, 2018. The number of shares which have been bought back on the electronic trading platform of the Frankfurt Stock Exchange (XETRA) within the framework of such tranche of the share repurchase program in the time period from October 8, 2018 until and including October 12, 2018 amounts to 313,728 shares. Shares were bought back as follows:Date Number of Shares Average Price Purchased Volume acquired (EUR) (EUR) 08- October 60,976 31.3073 1,908,993.92 -2018 09- October 61,767 30.9060 1,908,970.90 -2018 10- October 62,343 30.6209 1,908,998.77 -2018 11- October 64,535 29.5805 1,908,977.57 -2018 12- October 64,107 29.7779 1,908,971.84 -2018 Total 313,728 30.4242 9,544,913.00The underlying individual trades are published on the website of QIAGEN N.V. (http://corporate.qiagen.com/investor-relations/share-information/ share-buyback). The total number of shares which have already been bought back within the framework of such tranche of the share repurchase program from September 05, 2018 until and including October 12, 2018 amounts to 1,180,146 shares. The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V. Venlo, 16 October 2018 Managing Board ### Contacts: QIAGEN Investor Relations John Gilardi +49 2103 29 11711 e-mail:ir@qiagen.com Public Relations Dr. Thomas Theuringer +49 2103 29 11826 e-mail:pr@qiagen.com --------------------------------------------------------------------------- 16.10.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: QIAGEN N.V. Hulsterweg 82 5912 PL Venlo Netherlands Internet: www.qiagen.com End of News DGAP News Service
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden